Mueller AR et al. |
Severe neurotoxicity after liver transplantation: association between FK 506 therapy and hepatitis C virus disease. |
1994 |
Transplant. Proc. |
pmid:7527951
|
Platz KP et al. |
Causes of death following liver transplantation in FK 506- and cyclosporine-treated patients. |
1994 |
Transplant. Proc. |
pmid:7527952
|
Tai J et al. |
In vivo function of pig islet xenografts in immunosuppressed diabetic mice. |
1995 |
Transplant. Proc. |
pmid:8539968
|
Schreier MH et al. |
Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties? |
1993 |
Transplant. Proc. |
pmid:7679818
|
Felldin M et al. |
Rescue therapy with Tacrolimus (FK506) in renal transplant recipients--a multicenter analysis. |
1995 |
Transplant. Proc. |
pmid:8540032
|
Tze WJ et al. |
Immunohistochemical studies of pig islet xenograft in rats immunosuppressed with FK 506. |
1994 |
Transplant. Proc. |
pmid:7513470
|
Kahan BD |
Cyclosporine: the base for immunosuppressive therapy--present and future. |
1993 |
Transplant. Proc. |
pmid:7679819
|
Tze WJ et al. |
Prolongation of pig islet xenograft survival in rats by local immunosuppression with FK 506. |
1994 |
Transplant. Proc. |
pmid:7513471
|
Zheng B et al. |
Effects of the new and highly active immunosuppressant, rapamycin, on lymphoid tissues and cells in vivo. |
1991 |
Transplant. Proc. |
pmid:1703717
|
Yabuuchi H et al. |
Prominent prolongation of islet xenograft survival in combination therapy with FK 506 and 15-deoxyspergualin. |
1991 |
Transplant. Proc. |
pmid:1703718
|
Todo S et al. |
Early trials with FK 506 as primary treatment in liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689886
|
McCauley J et al. |
The effects of FK 506 on renal function after liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689887
|
Facundo C et al. |
Results of a triple induction regime with tacrolimus, mycophenolate mofetil, and prednisone in renal transplantation. |
2002 |
Transplant. Proc. |
pmid:11959203
|
McDiarmid S et al. |
One hundred children treated with tacrolimus after primary orthotopic liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636564
|
Fraile P et al. |
Non-skin solid tumors as a cause of morbidity and mortality after liver transplantation. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715943
|
Rath T and Küpper M |
Comparison of inosine-monophosphate-dehydrogenase activity in patients with enteric-coated mycophenolate sodium or mycophenolate mofetil after renal transplantation. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715967
|
Ueno T et al. |
Renal dysfunction following adult intestinal transplant under tacrolimus-based immunosuppression. |
2006 Jul-Aug |
Transplant. Proc. |
pmid:16908274
|
Nakao A et al. |
Combined effect of donor-specific bone marrow transplantation via portal vein and FK506 on small bowel transplantation in the rat. |
2000 |
Transplant. Proc. |
pmid:11120044
|
Luk JM et al. |
Immunosuppressive effects of Tripterygium wilfordii polysaccharide on LPS-stimulated human monocytes. |
2000 |
Transplant. Proc. |
pmid:11120045
|
Abu-Elmagd KM et al. |
Monitoring and treatment of intestinal allograft rejection in humans. |
1993 |
Transplant. Proc. |
pmid:7680150
|
Undre NA et al. |
Pharmacokinetics of tacrolimus: clinically relevant aspects. |
1999 |
Transplant. Proc. |
pmid:10576037
|
Mayer AD |
Four-year follow-up of the European Tacrolimus Multicenter Renal Study. |
1999 |
Transplant. Proc. |
pmid:10576038
|
Crespo-Leiro MG |
Calcineurin inhibitors in heart transplantation. |
2005 |
Transplant. Proc. |
pmid:16386614
|
Farghali H et al. |
A biochemical and 31P-NMR investigation of the effect of FK 506 and cyclosporine pretreatment on immobilized hepatocytes perifused with ethanol. |
1991 |
Transplant. Proc. |
pmid:1721284
|
Farghali H et al. |
FK 506 modulates D-galactosamine-induced hepatitis in rats. |
1991 |
Transplant. Proc. |
pmid:1721285
|
Harrison DM et al. |
Reduction in hospital stay after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623451
|
Morimoto T et al. |
Pancreaticoduodenal allotransplantation with FK 506 in the dog. |
1990 |
Transplant. Proc. |
pmid:1691550
|
Walker S et al. |
Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis. |
1998 |
Transplant. Proc. |
pmid:9636618
|
Sathyan S et al. |
A case of recurrent immunotactoid glomerulopathy in an allograft treated with rituximab. |
2009 |
Transplant. Proc. |
pmid:19917422
|
Schulz T et al. |
Tacrolimus/mycophenolate mofetil/steroid-based immunosuppression after pancreas-kidney transplantation with single shot antithymocyte globulin. |
1998 |
Transplant. Proc. |
pmid:9636623
|
Marzoa-Rivas R et al. |
Conversion of heart transplant patients from standard to sustained-release tacrolimus requires a dosage increase. |
2010 |
Transplant. Proc. |
pmid:20970591
|
Lodewijk L et al. |
Effect of liver regeneration on the pharmacokinetics of immunosuppressive drugs. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249561
|
Pan F et al. |
FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts. |
1994 |
Transplant. Proc. |
pmid:7518113
|
Florman S et al. |
Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen. |
2005 |
Transplant. Proc. |
pmid:15848672
|
Kato T et al. |
Steroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study. |
2005 |
Transplant. Proc. |
pmid:15848674
|
Frank B et al. |
Neurotoxicity of FK 506 in liver transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7682355
|
Söderdahl G et al. |
FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man. |
1995 |
Transplant. Proc. |
pmid:7533362
|
Matsuura T et al. |
Beneficial immunosuppressive effect of combined use of FK 506 and cyclosporine assessed by proliferative responses of cloned human T cells. |
1991 |
Transplant. Proc. |
pmid:1721316
|
Wynn C et al. |
High level of TGF-beta in organ transplantation might be due to rejection rather than calcineurin inhibitor medication. |
2002 |
Transplant. Proc. |
pmid:12176408
|
Mortensen DM et al. |
Calcineurin activity in tacrolimus-treated renal transplant patients early after and 5 years after transplantation. |
2006 |
Transplant. Proc. |
pmid:17098028
|
Loucaidou M et al. |
Late steroid withdrawal for renal transplant recipients on tacrolimus and MMF is safe. |
2005 |
Transplant. Proc. |
pmid:15919469
|
Bismuth H |
Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group. |
1995 |
Transplant. Proc. |
pmid:7533415
|
Ochiai T et al. |
Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group. |
1995 |
Transplant. Proc. |
pmid:7533419
|
Jain AB et al. |
Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant. |
1991 |
Transplant. Proc. |
pmid:1721347
|
Saito S et al. |
The pattern of rejection and susceptibility to different kinds of immunosuppression after combined liver, duodenum, and pancreas transplantation in swine--immunosuppressive drugs versus ex vivo immunomodulation of the allograft. |
1995 |
Transplant. Proc. |
pmid:7533420
|
Takaya S et al. |
Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients. |
1991 |
Transplant. Proc. |
pmid:1721348
|
Langrehr JM et al. |
First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV. |
2002 |
Transplant. Proc. |
pmid:12176487
|
Lorho R et al. |
Improved liver function and decreased hepatitis C viral load after tacrolimus was replaced by cyclosporine. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182838
|
Zucker K et al. |
Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123027
|
Iaria G et al. |
Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. |
2011 |
Transplant. Proc. |
pmid:21620043
|
Di Benedetto F et al. |
University of Modena experience in HIV-positive patients undergoing liver transplantation. |
2011 |
Transplant. Proc. |
pmid:21620066
|
Ronchetti F et al. |
Mucosal hyaluronic acid quantification in small bowel transplantation in pigs. |
1996 |
Transplant. Proc. |
pmid:8907950
|
Sun CK et al. |
Intensive care after orthotopic liver transplantation. |
1994 |
Transplant. Proc. |
pmid:7520627
|
Yin DP et al. |
Efficacy of FK506, leflunomide, anti-CD4, and CTLA4IG treatments in rat to mouse pancreas xenograft transplantation. |
2000 |
Transplant. Proc. |
pmid:10936320
|
Song Z et al. |
Protective effect of FK-506 in pig-to-rat islet xenotransplantation is abrogated by prednisolone. |
2000 |
Transplant. Proc. |
pmid:10936332
|
Prasad SJ et al. |
In vitro effects of cyclosporine and FK 506 on the renal cortex. |
1991 |
Transplant. Proc. |
pmid:1721380
|
Witzigmann H et al. |
Immunosuppression with sirolimus/tacrolimus combination in pancreas transplantation: 1-year results. |
2002 |
Transplant. Proc. |
pmid:12493472
|
Kusne S et al. |
Early infections in kidney transplant recipients under FK 506. |
1991 |
Transplant. Proc. |
pmid:1703364
|
Ushigome H et al. |
Immunosuppression in cadaveric renal transplant recipients from non-heart-beating donors in a single center. |
2002 |
Transplant. Proc. |
pmid:12176533
|
Citterio F et al. |
Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up. |
2002 |
Transplant. Proc. |
pmid:12176535
|
Weir M |
Impact of immunosuppressive regimes on posttransplant diabetes mellitus. |
2001 |
Transplant. Proc. |
pmid:11498201
|
Kaibori M et al. |
Inhibition of iNOS induction by FK506, but not by cyclosporine, in rat hepatocytes. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083347
|
Terakura M et al. |
Effects of peritransplant administration of hematopoietic growth factors on the development of chronic allograft rejection. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083380
|
Uchida J et al. |
Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism. |
2012 |
Transplant. Proc. |
pmid:22310596
|
el-Ghoroury M et al. |
Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123461
|
Hariharan S et al. |
Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123462
|
Mueller AR et al. |
Long-term follow-up in hepatitis C patients with respect to immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8962255
|
Jonas S et al. |
Posttransplant malignancy and newer immunosuppressive protocols after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8962257
|
Madariaga JR et al. |
The long-term efficacy of multivisceral transplantation. |
2000 |
Transplant. Proc. |
pmid:10995918
|
Harihara Y et al. |
Effects of interferon alpha/beta on cardiac allografts. |
1996 |
Transplant. Proc. |
pmid:8658645
|
Tze WJ et al. |
Long-term survival of islet allografts in diabetic rats treated with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721411
|
Shinozuka N et al. |
Correlation between simplified immunocompetence assay and clinical graft states in kidney or liver transplant recipients. |
1996 |
Transplant. Proc. |
pmid:8658649
|
McCarter JF et al. |
FK 506 protects brain tissue in animal models of stroke. |
2001 |
Transplant. Proc. |
pmid:11377571
|
Baran DA et al. |
Predictors of early renal insufficiency in cardiac transplant recipients initiated on tacrolimus. |
2002 |
Transplant. Proc. |
pmid:12176609
|
Takahashi Y et al. |
Pharmacokinetic Profile of Twice- and Once-daily Tacrolimus in Pediatric Kidney Transplant Recipients. |
|
Transplant. Proc. |
pmid:28104153
|
Zhou S et al. |
Tacrolimus enhances the invasion potential of hepatocellular carcinoma cells and promotes lymphatic metastasis in a rat model of hepatocellular carcinoma: involvement of vascular endothelial growth factor-C. |
2011 |
Transplant. Proc. |
pmid:21911157
|
Kauffman HM et al. |
Drug regimens affect cadaveric kidney graft survival. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267176
|
Sicilia-Castro D et al. |
Reconstruction of a severe facial defect by allotransplantation in neurofibromatosis type 1: a case report. |
2011 |
Transplant. Proc. |
pmid:21911174
|
Hummel AD et al. |
Application of artificial neural networks in renal transplantation: classification of nephrotoxicity and acute cellular rejection episodes. |
2010 |
Transplant. Proc. |
pmid:20304167
|
Ettenger RB |
New immunosuppressive agents in pediatric renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9723350
|
Collin C et al. |
Sublingual tacrolimus as an alternative to intravenous route in patients with thoracic transplant: a retrospective study. |
2010 |
Transplant. Proc. |
pmid:21168693
|
Li ZY et al. |
Analytical performance of the Abbott Architect i2000 tacrolimus assay in Chinese patients after renal transplantation. |
2010 |
Transplant. Proc. |
pmid:21168731
|
Moray G et al. |
Comparison of histidine-tryptophan-ketoglutarate and University of Wisconsin in living-donor liver transplantation. |
2006 |
Transplant. Proc. |
pmid:17175334
|
Nojima M et al. |
Immunosuppression Modification by Everolimus With Minimization of Calcineurin Inhibitors Recovers Kidney Graft Function Even in Patients With Very Late Conversion and Also With Poor Graft Function. |
|
Transplant. Proc. |
pmid:28104155
|
Dikow R et al. |
Blood pressure profile and treatment quality in liver allograft recipients-benefit of tacrolimus versus cyclosporine. |
2004 |
Transplant. Proc. |
pmid:15251373
|
Hasegawa S et al. |
FK 506 and cyclosporine: effects and side effects in canine lung transplantation. |
1991 |
Transplant. Proc. |
pmid:1721443
|
Wada H et al. |
Dose response to FK 506 in canine lung transplantation. |
1991 |
Transplant. Proc. |
pmid:1721444
|
Groth CG et al. |
New immunosuppressive drugs in transplantation. |
1993 |
Transplant. Proc. |
pmid:7689274
|
Thiru S et al. |
Pathological studies in canine and baboon renal allograft recipients immunosuppressed with FK-506. |
1987 |
Transplant. Proc. |
pmid:2445086
|
McMaster P and Buist L |
FK 506 in transplantation. |
1993 |
Transplant. Proc. |
pmid:7689275
|
Percy C et al. |
Impact of Acute Infection Requiring Hospitalization on Tacrolimus Blood Levels in Kidney Transplant Recipients. |
2017 |
Transplant. Proc. |
pmid:29149962
|
Krämer BK et al. |
Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials. |
2017 |
Transplant. Proc. |
pmid:29149958
|
van den Berg AP et al. |
Recurrent HCV infection reduces the requirement for tacrolimus after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267375
|
EscartÃn A et al. |
Orthotopic small bowel transplantation in pigs without steroids. |
1999 |
Transplant. Proc. |
pmid:10500720
|
Hutchinson IV et al. |
Differences in the mode of action of cyclosporine and FK 506. |
1998 |
Transplant. Proc. |
pmid:9636388
|
Hashi S et al. |
Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients. |
2014 |
Transplant. Proc. |
pmid:24767342
|
Granot E et al. |
Monitoring of Epstein-Barr virus serology in children after liver transplant: lack of clinical correlation. |
2000 |
Transplant. Proc. |
pmid:10856551
|
Carl S et al. |
Combining FK 506 and mycophenolate mofetil for the treatment of acute corticosteroid-resistant rejection following kidney transplantation: a new therapeutic concept. |
1998 |
Transplant. Proc. |
pmid:9636502
|
Budde K et al. |
Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months. |
1998 |
Transplant. Proc. |
pmid:9636503
|
Friemann S et al. |
Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636504
|